Clinical Trials Browser

Phase 1/2 × Pancreatic Neoplasms × sotorasib × Clear all

NCT05251038 2023-05-11

Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms